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The use of purified self-antigens can facilitate the further analysis of pathogenic 
mechanisms in autoimmunity (1,  2). This report describes the isolation of the 
nephritogenic antigen of anti-tubular basement membrane (a-TBM)l-induced 
interstitial nephritis. First described by Steblay and Rudofsky (3) over a decade 
ago,  this experimental  lesion  is  now induced in a  variety  of inbred strains  of 
mice, rats,  and guinea pigs after an injection of rabbit  renal tubular basement 
membrane (renal tubular antigen; RTA) in complete Freund's adjuvant (CFA). 
Disease-susceptible  rodents  develop  a-TBM  antibodies  after  9-10  d,  and  an 
intense interstitial infiltrate by 2-7 wk, depending on the species (3-5).  Pheno- 
typic characterization of the predominantly mononuclear cell infiltrate reveals 
the presence of an admixture of T cells, B cells, macrophages, and natural killer 
cells (6, 7). Additional studies have provided insights into the immunoregulation 
(8, 9), effector mechanisms (10,  11), and immunogenetics of disease expression 
(12,  13). Regarding the last of these, several  groups have analyzed susceptibility 
to  a-TBM  disease  in  different  rat  strains  (5,  14-16).  Certain  strains  (LEW, 
MAXX, and W/F, for example) do not develop disease, in part,  because they 
lack the appropriate nephritogenic tubular antigen expressed by the prototypi- 
cally  susceptible BN rat (5,  12,  14).  This difference among rat strains  can be 
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used  to advantage  in  the  process of identifying  or  selecting  relevant  a-TBM 
antibodies. 
The RTA used to induce a-TBM disease consists of >15 proteins,  as shown 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (un- 
published observations). In our approach to the isolation of the relevant nephri- 
togenic antigen we made the following assumptions: (a) a  single protein in RTA 
could be responsible for causing disease, (b) the nephritogenic determinant would 
be TBM specific, (c) this moiety would exist in BN rat TBM but not in LEW rat 
TBM,  and  (d) an  a-TBM  monoclonal  antibody (mAb)  to  such a  determinant 
could  reversibly  bind  it  under  appropriate  experimental  conditions.  Conse- 
quently, we used immunoaffinity chromatography with a relevant a-TBM-mAb 
to isolate a single antigen that is capable of inducing a-TBM disease in susceptible 
hosts. Biochemical analyses reveal this antigen to be a noncollagenous glycopro- 
tein.  Because coilagenase-solubilized  RTA  (SRTA),  at  an  otherwise  nephrito- 
genic dose, is rendered innocuous with selective removal of this disease-causing 
moiety, we believe that the purified glycoprotein may represent the antigen  of 
a-TBM  disease.  Immunoelectron  microscopic  studies  have  precisely  localized 
this determinant along and adjacent to the tubular basement membrane. These 
data indicate that  one glycoprotein is responsible for the induction  of a-TBM 
disease in this model. 
Materials and Methods 
Animals.  SJL and  BALB/c mice were obtained from The Jackson Laboratory, Bar 
Harbor, ME. (SJL ×  BALB/c)F~ mice were bred in our own facility. BN and LEW rats 
were purchased from Charles River Breeding Laboratories, Inc., Wilmington,  MA. Strain 
XIII guines pigs were a gift from Ulrich Rudofsky, Kidney Disease Institute,  New York 
State Department of Health, Albany, NY. Additional strain XIII guinea pigs were obtained 
from the University of Texas Veterinary Resource Division, Bastrop,  TX. All animals 
were maintained by the Department of Laboratory and Animal Medicine,  University of 
Pennsylvania School of Medicine. 
Preparation of  Renal Tubular Antigen.  Rabbit RTA was isolated by a differential sieving 
technique (17). Highly enriched basement membrane fragments were sonicated,  lyophi- 
lized, and stored at -70°C. SRTA was made from these lyophilized  membranes using 
bacterial  collagenase  (CLS IV;  Worthington,  Division of Cooper Biomedical,  Malvern, 
PA) digestion in the presence of protease inhibitors  (18). 
Immunofluorescence Analysis.  Hybridoma  culture  supernatants  were  overlayed  on 
cryostat sections of snap-frozen  mouse or rat kidneys. After a 30 min incubation,  sections 
were washed in phosphate-buffered saline (PBS), incubated for 30 min with fluoresceini- 
sothiocyanate (FITC)-conjugated anti-mouse IgG, washed again, and covered with glyc- 
erol  containing  phenylenediamine  (19).  Direct  immunofluorescence  (IF)  of nephritic 
guinea pig kidneys was performed with FITC-conjugated anti-guinea pig IgG. 
Monoclonal Antibody Production.  Fusion  techniques were adapted from those of Mc- 
Kearn (20) and Kennett (21). Fusion supernatants were screened using indirect IF, and 
subcloning was done in soft agar (22) or by limiting dilution  (23). Ascites was produced 
in (SJL × BALB/c)FI mice after pristane priming,  a-TBM mAh (anti-3M-1) was obtained 
using lymph node (LN) cells from an SJL mouse subcutaneously immunized  with RTA in 
CFA. Anti-29M-1 mAb (TBM and glomerular basement membrane [GBM]-binding)  was 
obtained in  a  separate fusion  using  LN cells from an  SJL  mouse also subcutaneously 
immunized with RTA in CFA. 
A~inity Chromatography.  50% saturated ammonium sulfate (SAS) precipitates  of mAb 
ascites were purified on a protein A-Sepharose CL-4B affinity column (Pharmacia  Fine 
Chemicals,  Piscataway,  NJ).  Purified anti-3M-1  and  anti-29M-1  antibodies were then 292  ANTIGEN  OF  ANTI-TUBULAR BASEMENT MEMBRANE DISEASE 
coupled to Sepharose 4B (2 mg antibody/ml Sepharose). SRTA was passed over individual 
mAb affinity columns, and the bound protein was reverse eluted with 0.1 M citrate buffer 
in 3  M  KCI, pH 2.5 into neutralizing buffer. Eluted aliquot, of 100-200 #g of protein 
were dialyzed against 0.1  M phosphate buffer, pH 8.0 and concentrated under vacuum 
dialysis. Eluted protein from the anti-3M° 1 and anti-29M-1 affinity columns are designated 
3M-I and 29M-1, respectively. 
Gel Electrophoresis.  9% SDS-PAGE gels of pre-column SRTA and column eluates were 
performed by the slab  technique of Laemmli (24).  The gel bands were developed with 
silver stain (25). 
Biochemical Analyses.  Amino acid analysis  was performed on protein samples hydro- 
lyzed in  6  N  HCI at  ll0°C  for 24  h  using a  Beckman  121MB amino acid analyzer 
(Beckman  Instrument,  Inc.,  Fullerton, CA).  Neutral sugars  were determined by high 
pressure liquid chromatography on protein samples hydrolyzed with trifluoroacetic acid 
at 100°C for 5 h. 
Solid Phase Radioimmunoassay (RIA).  25 #l of antigen (10 #g/mi) in 0.1  M phosphate 
buffer, pH 8, were added to individual wells of a 96-well,  V-bottomed polyvinyl chloride 
microtiter plate (Cook Products/Dynatech Laboratories, Alexandria, VA) and were in- 
cubated overnight at 4°C. The wells were then blocked with 4% bovine serum albumin 
(BSA) for 1 h and washed; 25 #l of serially diluted anti-3M-1 ascites, anti-29M-1 ascites, 
or affinity-purified mouse IgG (as a specificity control) were added. After incubation at 
22°C for 2 h, plates were washed and ~2SI-anti-mouse  IgG was added for 2 h at 220C. 
After thorough washing,  the wells  were cut and counted. Activity of wells  lined with 
eluate was compared with that of wells lined with equivalent amounts of SRTA, column 
filtrate, and BSA. 
Induction of Disease.  Strain XIII guinea pigs receiving a single subcutaneous injection 
of 50 #g of antigen in CFA were sacrificed 18-22 d  later.  Kidneys (hematoxylin and 
eosin-stained sections) from these animals were examined for pathology, and the degree 
of tubuiointerstitial disease assessed on a previously published (26), semiquantitative scale 
(0-4+). Direct IF (see above) was also performed. 
lramunoelectron Microscopy.  This methodology has been previously described in detail 
(27). Briefly, BN rat kidneys were fixed by in vivo formaldehyde perfusion. 8-#m frozen 
sections were mounted on albumin-coated slides and reacted with borohydride, followed 
by normal goat serum, primary mAb (or normal mouse serum), goat anti-mouse IgG, 
and mouse peroxidase-antiperoxidase complex, with appropriate PBS washes. Tissue was 
treated with OsO4, embedded in plastic,  cut into ultrathin sections, mounted on uncoated 
grids, and photographed without any further staining. 
Results 
Assessment  of Anti-3M-1  Antibody  Specificity  by IF.  Indirect  IF  of anti-3M-1 
mAb  on  normal  SJL  kidney  sections  revealed  linear  staining  of the  tubular 
perimeter corresponding to the region of the tubular basement membrane (Fig. 
1A). While there was also staining of Bowman's capsule, intraglomerular struc- 
tures themselves were devoid of IF, except for minor granular mesangial staining 
(Fig.  1A). This slight mesangial staining is identical to that seen by direct IF of 
normal SJL kidney sections (28). A similar pattern of IF with anti-3M-1 antibody 
was seen by indirect  IF on normal  BN rat  kidney sections (Fig.  1 B),  whereas 
normal LEW rat kidney sections were negative (Fig. 1 C). When anti-29M-1  mAb 
was used in indirect IF, in contrast to anti-3M-1,  there was equivalent staining 
of both the TBM and the GBM.  Further distinguishing  anti-29M-I  from anti- 
3M-1  antibody was the ability of the former to stain both normal BN and LEW 
rat  tubules  to  the  same  extent  (data  not  shown).  Thus,  anti-3M-1  antibody c
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FIGURE 2.  Solid phase  RIA of anti-3M-I antibody affinity column eluate. (A) Wells lined 
with column eluate (O), SRTA (ll), column filtrate (SRTA adsorbed on the anti-3M-1 antibody 
affinity column) (A), or BSA (*) were reacted with serial dilutions of anti-3M-I antibody (7.5 
mg/ml from  SAS-precipitated ascites).  The column eluate was  markedly enriched for  the 
3M-1  epitope. (B) Wells lined with column eluate were reacted with serial dilutions of anti- 
3M-1 antibody (same stock as in A) (O), anti-29M-1 antibody (25 mg]ml from SAS-precipitated 
ascites)  (1"1), or affinity-purified mouse IgG (5 mg/ml) (A). Column eluate bound anti-3M-1 
antibody specifically. 
appears to recognize both TBM and Bowman's capsule  2. Anti-3M-1 binds normal 
BN rat kidney, but not LEW rat kidney, an important distinguishing character- 
istic (5,  12,  14). 
Evaluation  of Affinity  Chromatography Eluates.  The material eluted from anti- 
3M-1-Sepharose 4B affinity columns typically represented ~0.05% of the start- 
ing renal TBM preparation. Pre-column SRTA, column filtrate, and eluate were 
analyzed in an indirect, solid phase RIA with anti-3M-1  (Fig. 2A). The column 
eluate was markedly enriched (four orders of magnitude) for the 3M-1  epitope, 
compared with pre-column SRTA. Conversely, column filtrate appeared to be 
relatively depleted of this determinant. To exclude the possibility that column 
eluate nonspecifically bound 3M-1 antibody, eluate-lined wells were reacted with 
anti-3M-1, anti-29M-1, or mouse IgG in the indirect RIA. Fig. 2B demonstrates 
2 Double labelling  immunofluorescence  performed by Dr.John Hoyer (University  of Pennsylvania) 
(using anti-3M-I mAb, FITC-conjugated anti-mouse IgG, and rhodamine-conjugated anti-Tamm- 
Horsfall protein tracking antibody) demonstrated anti-3M-1 staining of the basement membrane of 
proximal tubules only. CLAYMAN  ET  AL.  295 
that column eluate (3M-l) was bound by anti-3M-1  antibody, but not by either 
anti-29M-1  or mouse IgG. Thus, the material eluted from the anti-3M-1  affinity 
column was specifically enriched for the 3M-1 epitope. 
3M-1  was  then  further  evaluated  by  SDS-PAGE.  Fig.  3  demonstrates  that 
silver-stained 3M-1  is predominantly composed of a 48,000 mol wt band, which 
was identical under both reduced (Fig. 3 C) and nonreduced (D) conditions. For 
comparison, SDS-PAGE of collagenase (A) and pre-column SRTA (B) is shown. 
Both the absence of collagenase bands from 3M-1 and the heterogenous nature 
of pre-column SRTA are evident. 
Amino acid analysis of 3M-1  (Table I) indicates that this protein is devoid of 
3-hydroxyproline and hydroxylysine residues, and contains <6 residues per 1,000 
of 4-hydroxyproline, suggesting that 3M-1  is noncollagenous in nature. Neutral 
sugar analysis (Table  I) demonstrates significant amounts of glucose, and only 
traces of galactose, mannose, and fucose. 
29M-1  antigen was purified as a  control protein from an anti-29M-1  affinity 
column using pre-column SRTA as a starting material. Solid phase RIA analysis 
of the column eluate revealed strong reactivity with anti-29M-1  and SDS-PAGE 
showed two major bands of 29,000 and 45,000 mol wt (data not shown). 
Evaluation of the Ability of the 3M- 1 Glycoprotein  to Induce ot-TBM Disease.  Strain 
XIII guinea pigs, a highly susceptible strain, were injected with 50 gg of various 
antigen  preparations  in  CFA  and  were  sacrificed  18-22  d  later.  Table  II 
documents the  nephritogenic  nature  of crude  SRTA  and  the  purified  3M-1 
moiety. Fig.  4A  demonstrates the extent of tubulointerstitial destruction after 
FIGURE 3.  SDS-PAGE of the  3M-I  protein.  (A and  B)  Bacterial  collagenase and  SRTA, 
respectively (both reduced); (C) reduced 3 M-1; (D) unreduced 3M-1. The 3M-1  lanes reveal a 
predominantly  48,000  mol  wt  protein,  with  a  few much  fainter,  higher  molecular weight 
bands. 3M-1  is devoid of both bacterial collagenase contamination and most SRTA proteins. 296  ANTIGEN  OF  ANTI-TUBULAR  BASEMENT  MEMBRANE  DISEASE 
TABLE  I 
Biochemical Analysis of 3M- 1 
Residues  Percent of  Amino acids  Neutral sugars  per 1,000  protein 
Cysteic acid  11.32 
3-Hydroxyproline  0.00 
Methionine sulfoxide  2.64 
4-Hydroxyproline  5.88 
Aspartic acid  49.58 
Threonine  15.27 
Serine  39.41 
Glutamic acid  139.38 
Proline  81.20 
Glycine  161.80 
Alanine  154.09 
Cystine  0.00 
Valine  49.22 
Methionine  0.00 
Isoleucine  45.30 
Leucine  93.44 
Tyrosine  0.51 
Phenylalanine  28.94 
Hydroxylysine  0.00 
Lysine  52.44 
Histidine  20.41 
Arginine  49.16 
Glucose  6-8 
Galactose  Trace 
Fucose  Trace 
Mannose  Trace 
TABLE  II 
Induction of Disease in Strain XIII Guinea Pigs 
Antigenic preparation  n  Pathologic score* 
3M-I  4  2.9 --+ 0.6 
SRTA  3  2.2 ± 0.4 
Column filtrate  s  3  0.0 + 0,0 
29M-1  3  0.0 ± 0.0 
All guinea pigs received 50 ~g of the designated preparation in CFA, 
subcutaneously. Animals were sacrificed 18-22 d later and their kidneys 
processed as described in Materials and Methods. 
* Hematoxylin and eosin-stained sections were evaluated on a scale of 
0-4 describing the extent of cortical tubulointerstitial involvement with 
mononuclear cell infiltrates. 
at SRTA  that  had  been  doubly  adsorbed  over  the  anti-3M-1  affinity 
column. 
immunization with 3M-1  antigen, and  Fig. 4B shows linear IF in the TBM  zone 
of the  diseased  kidney.  Serum  from  nephritic  guinea  pigs stained  BN  but  not 
LET  kidneys (data not shown).  By contrast,  SRTA  that had been  twice passed 
over an anti-3M-1  column,  and was depleted of the  3M-1  epitope (see Fig. 2A, 
above),  did  not  cause  disease  (Table  II).  Similarly,  immunization  with  29M-1 
antigen,  which,  by  IF criteria exists  in  the  GBM  as  well as  the  TBM,  did  not 
result in renal pathology (Table II). 
Electron Immunohistochemical  Localization  of the 3M-1 Determinant.  These data ,
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confirm and extend observations by indirect IF on the distribution of 3M-1. The 
antigen was demonstrated on TBM (Fig.  5A),  predominantly in the interstitial 
aspect of these structures (Fig. 5, C and D). The inner aspects of the TBM (closer 
to the tubular cell) were consistently negative (Figs. 5, C and D). Large, interstitial 
collagen fibers were often, but not always, coated with the antigen (Fig. 5, A, C, 
and D). The interstitial aspect of the arteriolar smooth muscle basement mem- 
brane was occasionally positive (data not shown). Bowman's capsule was consist- 
ently positive with the antibody (Fig. 5A), reacting in a similar pattern to that of 
TBM; i.e., the interstitial aspects were positive, whereas the glomerular aspects 
were negative. The GBM and the mesangial matrix were consistently negative 
(Fig.  5, A and B), confirming one of the original criteria for relevance of anti- 
3M-1 antibody--that it is TBM specific and unreactive with GBM. 
Altogether, these data document that the 3M-1 antigen is primarily located in 
the interstitium and on the interstitial aspect of the TBM. Furthermore, 3M-1 is 
not a demonstrable glomerular antigen. 
Discussion 
Observations from both clinical and experimental studies document the in- 
volvement of destructive immunopathogenic mechanisms in the tubulointerstitial 
nephropathies (reviewed in 29 and 30).  Attempts to elucidate relevant immu- 
nologic processes leading to interstitial damage have relied heavily on animal 
models that use complex antigen preparations to induce pathologic renal lesions. 
The availability of a  single nephritogenic antigen  would obviously permit  a 
clearer understanding of afferent, regulatory, and efferent factors in the immune 
response. The present investigation describes the isolation of such a molecule. 
3M-1  is a  48,000  mol wt glycoprotein derived from bacterial collagenase- 
digested TBM. This antigen is capable of inducing a-TBM antibodies and severe 
interstitial nephritis in susceptible hosts. Because the 3M-1 antigen lacks hydrox- 
ylysine and  3-hydroxyproline residues, and contains a  very low amount of 4- 
hydroxyproline, it probably derives from noncollagenous glycoproteins that have 
been previously described (31) as constituents of basement membranes of various 
origins. Interestingly, the carbohydrate portion of 3M-1 is comprised of glucose, 
largely to the exclusion of other frequently encountered sugar moieties, partic- 
ularly mannose and galactose. Although uncommon, similar glycoproteins have 
been isolated from renal tissue by other investigators.  Shihata and Nagasawa 
(32), for example, have described a nephritogenic glycoprotein capable of causing 
glomerular disease that, similarly, possessed  glucose as its predominant neutral 
FIGURE 5.  Electron immunohistochemical  localization of 3M-I in normal rat kidney. (A) The 
interstitial aspect of the TBM reacted strongly with the antibody. The antigen is present in 
the interstitial extracellular matrix and in the interstitial aspect of Bowman's capsule (B). The 
GBM and the mesangium (M) do not react'with the antibody, x 2,800. (B) Detail of glomerular 
capillary loops. The GBM and mesangial matrix (Mm) are negative. X 5,100. (C) Detail of 3M-1 
localization. Both TBM react with the antibody. The antigen predominates in the outermost 
(interstitial) aspect of the TBM (arrowheads).  The antigen is also found coating interstitial 
collagen fibers (C) cut in cross-section, x  24,000. (D) Detail of TBM and interstitial collagen 
(C) fibers. The antigen predominates in the interstitial aspects of the TBM. The collagen fibers 
(in longitudinal section) are coated by the antigen, x  23,000. Abbreviatons used in figure: Bb, 
brush border; CL, capillary lumen; En, endothelial cell; M, mesangium; N, nucleus; Pe, parietal 
epithelial cell; To, tubular cell; Tl, tubular lumen; Us, urinary space; Ve, visceral epithelial cell. CLAVMAN  ~T  AL.  299 300 CLAYMAN  ET  AL.  301 
sugar. Their method of antigen preparation, IF localization, and induction of a 
proliferative glomerulonephritis all distinguish it from 3M-1. Finally, the possi- 
bility that 3M-1  is the nephritogenic moiety of rabbit RTA which causes ot-TBM 
disease is suggested by the demonstration that selective depletion of 3M-1  from 
a pre-column SRTA preparation results in the loss of its nephritogenic capabili- 
ties. 
Several  previous  studies  have  explored  the  molecular nature  of basement 
membranes in general, TBM in particular, and the relevant component of RTA 
that produces a-TBM disease. All basement membranes have a common struc- 
tural backbone: type IV collagen. The amino- and carboxy-terminal procollagen 
peptides of this collagen consist of noncollagenous sequences with intrachain or 
interchain disulfide bonds. Basement membranes, including those found in the 
kidney, also have several noncollagenous components: entactin, heparan sulfate 
proteoglycan, and laminin, which are integrated into the basement membrane 
via covalent and noncovalent bonds (31). Thus noncollagenous antigens, includ- 
ing 3M-l, could derive either from the noncollagenous domains of procollagen, 
or from other noncollagenous components. However, the present study dem- 
onstrates that the ultrastructural  localization of 3M-1  is distinctively different 
from that of type IV collagen (33, 34), entactin (27), heparan sulfate proteoglycan 
(34),  and  laminin  (33,  35).  In  addition  to  the  different  localization  within 
basement membranes, all these known components of basement membranes are 
present in the GBM. This is in contrast to 3M-l, which is not demonstrable in 
GBM.  These considerations suggest that 3M-1  is either a  previously unknown 
component of basement membranes, or an interstitial antigen that, in vivo, is in 
close apposition to some basement membranes. The ultrastructural localization 
favors the second possibility. 
Several groups have investigated the glycoprotein nature of the TBM per se. 
Ferwerda et al. (36) isolated TBM glycoproteins after collagenase digestion of 
bovine RTA. Two distinct glycoproteins were identified, one of which was TBM 
specific, the other of which had epitopes shared by both TBM and GBM. This 
parallels our experience with 3M-1 and 29M-1, the former being associated with 
the TBM and not GBM, and the latter present in both TBM and GBM. Butkowski 
et al. (37) used SDS solubilization to study the glycoprotein-rich component of 
rabbit  TBM.  By  SDS-PAGE  analysis,  they  documented at  least  18  distinct 
moieties in this fraction, ranging in molecular weight from 18,500 to 1,000,000. 
In  these  studies  the  potential  pathogenicity  of individual  proteins  was  not 
assessed,  nor  was  the  location  of these  determinants  evaluated  by  electron 
microscopy. Paul and Carpenter (38) analyzed the antigenic profile of the rat 
proximal  tubular  basement  membrane using  serologic patterns  of reactivity. 
They also were able to discern at least two distinctive determinants, although 
these  were not  isolated  nor  further characterized.  Interestingly,  neither was 
present in LEW rat TBM, and both appeared to be encoded outside of the major 
histocompatibility complex (MHC). These observations are consistent with what 
is known of the target antigen of ot-TBM disease. LEW rats lack this determinant 
(and are consequently protected from the induction of a-TBM  disease), and 
genetic mapping suggests that the relevant locus exists on a non-MHC chromo- 
some (12). Very recent data (13) indicate that the gene for the TBM nephrito- 302  ANTIGEN  OF  ANTI-TUBULAR  BASEMENT  MEMBRANE  DISEASE 
genic antigen exists in the first linkage group of the rat, which is homologous to 
chromosome 7 of the mouse. 
Few  investigations  have  attempted  to  isolate  purified  antigens  capable  of 
inducing autoimmune renal disease. Wakashin et al. (39), however, have reported 
on a nephritogenic antigen in ot-TBM disease. They digested human TBM with 
trypsin, and used a series of physicochemical methods to purify a 30,000 mol wt 
determinant that was capable of inducing a-TBM antibody-associated interstitial 
nephritis in outbred goats and BALB/c mice. Three considerations make these 
observations somewhat unusual.  First, because trypsin digestion was used, one 
cannot exclude  the  possibility that  this antigen  was  enriched  for  collagenous 
components, rather than  glycoprotein; unfortunately, amino acid analysis and 
immunoelectron microscopy were not provided. Previous experience with renal 
basement membrane collagen suggests that this basement membrane constituent 
is  generally  not  pathogenic  (unpublished  observations).  Secondly,  the  TBM 
antigen isolated by Wakashin et al. (39) caused, in addition to interstitial nephritis, 
a proliferative glomerulonephritis. Such glomerular lesions have not been seen 
as part of the spectrum of classical a-TBM disease, and raise the issue of exactly 
how their moiety relates to the traditional experimental model of tubulointersti- 
tial  disease.  Lastly,  it  is  surprising that  C57BL/6  mice immunized with  their 
TBM antigen did not mount an a-TBM antibody response. Previous investiga- 
tions (4, 28) using tubular antigen have documented a-TBM antibody production 
among all  mouse  strains  thus  far  tested  (including  C57BL/6),  regardless  of 
susceptibility to nephritic disease. Using a different approach, Zanetti and Wilson 
(40) have suggested that, in the rat model of a-TBM disease, a  42,000 tool wt, 
collagenase-solubilized component of bovine and BN rat TBM may be a relevant 
moiety for disease induction. The nephritogenic capabilities of this determinant, 
however, were not directly analyzed. 
Finally, immunoelectron  microscopy  has  revealed  the  fine  detail  of  3M-1 
distribution.  3M-1  is predominantly localized to the most lateral aspects of the 
TBM, bordering, and adjacent to the interstitial region; the glomerulus is devoid 
of such determinants. As discussed above, this unique distribution distinguishes 
3M-1  from other  known protein  constituents of renal  basement  membranes, 
including type IV collagen (33, 34), entactin (27), heparan sulfate proteoglycan 
(34), and laminin (33, 35). Consequently, it would appear that the 3M-1 epitope 
identifies a unique renal interstitial and/or basement membrane-associated gly- 
coprotein. 
Summary 
Using monoclonal antibody affinity chromatography, we isolated a 48,000 mol 
wt,  glucose-rich glycoprotein (3M-l)  from collagenase-solubilized rabbit  renal 
tubular basement membrane (SRTA). The purified 3M-1  protein is noncollage- 
nous, and is capable of inducing anti-TBM (tubular basement membrane) anti- 
bodies and interstitial nephritis in susceptible hosts. Further, when SRTA, at a 
normally nephritogenic dose, was selectively depleted of 3M-l,  it lost its ability 
to induce disease. As shown by immunofluorescent techniques, 3M-1 appears to 
be  localized  on  rodent  TBM  to  the  exclusion  of  the  glomerular  basement 
membrane, but was lacking in the TBM of the LEW rat, a  strain devoid of the CLAYMAN ET  AL.  303 
relevant antigen ofanti-TBM disease. Immunoelectron microscopy revealed that 
3M-1  was associated  with  the most  lateral  aspect of the TBM,  which borders, 
and lies in the interstitium. These results indicate that 3M-1 is the nephritogenic 
antigen producing experimental anti-TBM disease. 
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